Welcome to Law.com Class Actions: Critical Mass, Law.com’s weekly briefing for class action and mass tort attorneys. I’m Amanda Bronstad. Forty-two states signed on to the proposed $26 billion opioid settlement — the first of several steps the deal must go through before distributing payments to governments. After U.S. District Judge Charles Breyer banned associates from working on the McKinsey & Co. opioid litigation during the holidays, lead counsel Elizabeth Cabraser responded with: “The nation’s associates would thank you.” Trials over Risperdal, made by Johnson & Johnson’s Janssen Pharmaceuticals, are ramping back up.
Feel free to reach out to me with your input. My email is [email protected], or follow me on Twitter: @abronstadlaw.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Not a Bloomberg Law Subscriber?
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]